by University of Pittsburgh Ball-and-stick model of the dopamine molecule, a neurotransmitter that affects the brain’s reward and pleasure centers. Credit: Jynto/Wikipedia Why do patients who receive antipsychotic medications to manage schizophrenia and bipolar disorder quickly gain weight and develop prediabetes and hyperinsulemia? The question remained a mystery for decades, but in a paper published today...
by Vanessa Wasta, Johns Hopkins University Photomicrograph of a mitochondrion, the energy-generating powerhouse in a human cell. Johns Hopkins Medicine researchers are studying how to recycle these organelles and perhaps, lead to new treatments for Parkinson’s disease. Credit: University of Wisconsin-Madison College of Agricultural and Life Sciences Researchers at Johns Hopkins Medicine are taking a...
by University of Bath Scientists at the University Bath have discovered a series of protein structures that are thought to be highly relevant to the onset of Parkinson’s disease. It is hoped that further analysis of these structures will open up a new avenue for potential treatment for a disease that is the fastest growing...
CREDIT: L.A. CICERO/STANFORD NEWS SERVICE In 2017, Stanford University researchers presented a new device that mimics the brain’s efficient and low-energy neural learning process. It was an artificial version of a synapse – the gap across which neurotransmitters travel to communicate between neurons – made from organic materials. In 2019, the researchers assembled nine of...
By Nick Lavars June 09, 2020 It is well known that consuming food and drink high in sugar is not great for us, but scientists are continuing to unravel the intricacies of how the sweet stuff drives negative health outcomes. The latest finding comes from researchers at the University of Michigan, who through studies in...
Controlling dopamine signalling by targeting the histamine receptor has been shown to be a promising strategy for preventing the progression of Huntington’s disease in mice Scientists have described a potential new therapeutic strategy for slowing down early-stage Huntington’s disease in a new study published today in eLife. The research in mice indicates that targeting the...
by Nanyang Technological University A promising molecular pair has offered hope that could lead to the development of a new treatment to slow down Parkinson’s disease, a study by Nanyang Technological University, Singapore (NTU Singapore) and Harvard University has found. Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease, affecting 7 to...
Posted Today This news or article is intended for readers with certain scientific or professional knowledge in the field. What happens when we give up? Inside the brain, a group of cells known as nociceptin neurons get very active before a mouse’s breakpoint. They emit nociceptin, a complex molecule that suppresses dopamine, a chemical largely associated with...
An international team of researchers has found evidence of dopamine in the brain playing a role in the pleasure people feel when they listen to music. In their paper published in Proceedings of the National Academy of Sciences, the group describes experiments they carried out with volunteers who were given a dopamine precursor or antagonist...
UNIVERSITY OF TEXAS AT SAN ANTONIO (San Antonio, Jan. 10, 2019) — Researchers at The University of Texas at San Antonio have revealed significant insight into cocaine addiction, a phenomenon which has grown significantly in the United States since 2015. Now new data by UTSA shows how the release of the neurotransmitter dopamine changes when...
